Evaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Participants 1 Year of Age and Older
Clinical trial NCT05844449 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05844449
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-11
- Primary completion
- 2029-07-30
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.